HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Post-ischemic therapy with CGS-19755 (alone or in combination with hypothermia) in gerbils.

Abstract
Hypothermia or a glutamate receptor antagonist may offer protection when used before or within seconds of an ischemic insult. In this experiment, we tested the efficacy of hypothermia (34 degrees C) versus CGS-19755 (a potent competitive N-methyl-D-aspartate (NMDA) receptor blocker) and their combination which was administered 0.5 h after a 5-min forebrain ischemic insult in gerbils. Morphological assessments were done in Group A at the end of 7 days while Group B was evaluated at 29 days. Each group had four sets of animals: saline treated controls; hypothermia treated; CGS-19755 treated; and a combination of CGS-19755 + hypothermia treated animals. Group A showed significant 'protection', i.e. minimal neuronal damage in the animals treated with hypothermia alone. Protection was evident in the cerebral cortex (P < 0.001), hippocampus CA1 (P < 0.01), and in the striatum (P < 0.05). There was no evidence of neuronal protection in the animals that had received either CGS-19755 alone or a combination of hypothermia and CGS-19755. In Group B (29 day assessment) the neuroprotective effects were not evident in any of the animals when compared to the controls. Behavioral testing with Morris water-maze testing showed no significant differences between the control and any of the treated animals. Our data suggests that 'post-ischemic' therapy with hypothermia may delay the effects of ischemia but does not offer significant long-term neuronal protection. Protection seen at 7 days is not evident at 29 days.(ABSTRACT TRUNCATED AT 250 WORDS)
AuthorsA Shuaib, T Waqar, T Wishart, R Kanthan
JournalNeuroscience letters (Neurosci Lett) Vol. 191 Issue 1-2 Pg. 87-90 (May 19 1995) ISSN: 0304-3940 [Print] Ireland
PMID7659298 (Publication Type: Journal Article)
Chemical References
  • Pipecolic Acids
  • selfotel
  • N-Methylaspartate
Topics
  • Animals
  • Brain Ischemia (drug therapy, pathology, therapy)
  • Combined Modality Therapy
  • Gerbillinae
  • Hypothermia, Induced
  • Injections, Intraperitoneal
  • Male
  • Maze Learning (drug effects)
  • N-Methylaspartate (antagonists & inhibitors)
  • Pipecolic Acids (administration & dosage, therapeutic use)
  • Prosencephalon (blood supply, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: